His primary interest is finding new mechanisms and treatments for heart rhythm disorders. His laboratory and clinical research programs are supported by National Institute of Health (NIH) R01 and American Heart Association (AHA) grants. Work in his laboratory investigates molecular arrhythmia mechanisms involving alterations in the functioning of myofilaments and calcium release channels. In addition, the lab is developing and testing new anti-arrhythmic therapies in animal models and in humans.